• 17 May 2016

    Onion, Garlic & Ginger hold promise for future medication

    Insufficient clinical data, lack of large scale and well defined investigation plan on wide scale on various territories with a common goal are some of the deterrents which are not permitting gelling of these three with allopathic medicines. If sole herbals are not very effective then the only option is to marry these with well defined and recommended allopathic medicine to make powerful formulae for existing medical problems.

  • 13 May 2016
    Rx to OTC switch: An overview

    The success of a drug molecule or formulation lies in its switching over to OTC (over the counter) genre from prescription drugs (Rx) over the years. No doubt critical therapy like chemotherapy, cardio medicines and others cannot /should not be promoted as OTC.

  • 5 May 2016
    ORAL CARE PRODUCTS

    ABOUT AUTHOR:
    Vinay Kumar Singh
    Chief Research Officer,
    Paramount Cosmetics India,
    Bangalore, Karnataka

  • 5 May 2016
    Why appetite loss during illness or diseases ?

    Loss of appetite during illness is a common and potentially debilitating phenomenon—in cancer patients, especially, it can even shorten lifespan. Researchers of the Scripps Research Institute (TSRI) have discovered how an immune system molecule hijacks a brain circuit and reduces appetite. Their discovery points to possible targets for treating loss of appetite and restoring a patient’s strength.

  • 5 May 2016
    IMPACT OF PATENT ON THE ACCESS AND PRICE OF LIFE SAVING DRUGS

    “After the colonial era, cost of drugs in India had inherited British patent law, and the average Indian citizen unable to afford pharmaceutical medicines.  So in 1970, India passed the Patent Act, which allowed Indian companies to make cheaper copies of another company’s drug (or other inventions) as long the manufacturing process was slightly different.

  • 5 April 2016
    HAIR COLOURANTS

    ABOUT AUTHOR:
    Vinay Kumar Singh
    General Manager-Technical,
    Mikasa Cosmetics Limited,
    Ahmedabad, Gujarat
    vinay.s@mikasacosmetics.com

  • The rising cost of raw materials, stringent regulatory requirements and increasingly competitive environment all are rapidly eroding the profit margins of many antibiotic manufacturers. BCC Research reveals in its new report that these challenges, and the growing problem of antibiotic resistance, have dramatically shifted the business models of some of the industry’s leading pharmaceutical companies.

  • 29 March 2016
    ADR MONITORING: AN ESSENTIAL NEED FOR BETTER HEALTH CARE AND SAFETY

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS
    Annu*, Priyanka
    Department of Pharmaceutical Sciences,
    Maharshi Dayanand University, Rohtak, Haryana, India.
    *annu.gvm@gmail.com

    ABSTRACT
    Adverse drug reaction (ADR) is the noxious and unintended response that occurs at the dose of drug normally used for prophylaxis, diagnosis or therapy of disease. ADRs cause a huge burden on the modern society because of the increase incidence of the morbidity and mortality. ADRs can occur with any class of drugs and the availability of the more and more number of therapeutics increases the risk of ADRs consequently. It has been found that the maximum numbers of ADRs occur more among infants and children and also they are generally more severe as compared to adults. ADRs are of particular interest in today’s practice because clinical trials are done in the limited number of the subjects and therefore the drug which is found safer in the clinical trial may produces serious ADRs. The most common reason for this is that the clinical studies generally have limited sample size and have low statistical power. Therefore the ADRs monitoring is an essential need for the better health care and therefore the health care centre should promotes the spontaneous monitoring, reporting, documentation and prevention of ADRs.

  • The money allocated for key centrally sponsored social schemes — Integrated Child Development Services (ICDS), Sarva Shiksha Abhiyan (SSA or universal education programme) and National Health Mission — has declined 10 percent, 7.5 percent and 3.6 percent over two years.

Subscribe to Pharmapedia